Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon (Q39240225)
Jump to navigation
Jump to search
scientific article published on 28 October 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon |
scientific article published on 28 October 2016 |
Statements
1 reference
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon (English)
1 reference
S Petta
M Barbara
S Attardo
L Bucci
F Ciccarese
G L Rapaccini
M Di Marco
E Caturelli
M Zoli
F Borzio
R Virdone
M Felder
F Morisco
L Benvegnù
A Gasbarrini
F G Foschi
A Masotto
G Nardone
A Colecchia
V Boccaccio
A Craxì
S Bruno
F Trevisani
C CammÃ
Italian Liver Cancer (ITA.LI.CA) Group
28 October 2016
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference